Correlation Between Iovance Biotherapeutics and T2 Biosystms

Can any of the company-specific risk be diversified away by investing in both Iovance Biotherapeutics and T2 Biosystms at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Iovance Biotherapeutics and T2 Biosystms into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Iovance Biotherapeutics and T2 Biosystms, you can compare the effects of market volatilities on Iovance Biotherapeutics and T2 Biosystms and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Iovance Biotherapeutics with a short position of T2 Biosystms. Check out your portfolio center. Please also check ongoing floating volatility patterns of Iovance Biotherapeutics and T2 Biosystms.

Diversification Opportunities for Iovance Biotherapeutics and T2 Biosystms

0.28

Correlation Coefficient

Iovance Biotherapeutics  T2 Biosystms

Modest diversification

The 3 months correlation between Iovance and TTOO is 0.28. Overlapping area represents the amount of risk that can be diversified away by holding Iovance Biotherapeutics and T2 Biosystms in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on T2 Biosystms and Iovance Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Iovance Biotherapeutics are associated (or correlated) with T2 Biosystms. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of T2 Biosystms has no effect on the direction of Iovance Biotherapeutics i.e., Iovance Biotherapeutics and T2 Biosystms go up and down completely randomly.

Pair Corralation between Iovance Biotherapeutics and T2 Biosystms

Given the investment horizon of 90 days Iovance Biotherapeutics is expected to generate 0.47 times more return on investment than T2 Biosystms. However, Iovance Biotherapeutics is 2.11 times less risky than T2 Biosystms. It trades about -0.04 of its potential returns per unit of risk. T2 Biosystms is currently generating about -0.15 per unit of risk. If you would invest  818.00  in Iovance Biotherapeutics on September 16, 2024 and sell it today you would lose (35.00) from holding Iovance Biotherapeutics or give up 4.28% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Iovance Biotherapeutics  vs.  T2 Biosystms

Iovance Biotherapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Iovance Biotherapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

T2 Biosystms

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days T2 Biosystms has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Pair Trading with Iovance Biotherapeutics and T2 Biosystms

The main advantage of trading using opposite Iovance Biotherapeutics and T2 Biosystms positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Iovance Biotherapeutics position performs unexpectedly, T2 Biosystms can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in T2 Biosystms will offset losses from the drop in T2 Biosystms' long position.

The idea behind Iovance Biotherapeutics and T2 Biosystms pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.